Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Mass Spectrometry

• Publication date

  2003-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/JMS.483PMID 12827635
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Toxicological detection of selegiline and its metabolites in urine using fluorescence polarization immunoassay (FPIA) and gas chromatography-mass spectrometry (GC-MS) and differentiation by enantioselective GC-MS of the intake of selegiline from abuse of methamphetamine or amphetamine

  2005cited by this paper
• Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization.

  2003cited by this paper
• New designer drug p-methoxymethamphetamine: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry.

  2003cited by this paper
• Drugs of Abuse Monitoring in Blood for Control of Driving Under the Influence of Drugs

  2002cited by this paper
• Determination of paramethoxyamphetamine and other amphetamine-related designer drugs by liquid chromatography/sonic spray ionization mass spectrometry.

  2002cited by this paper
• Toxicokinetics of Amphetamines: Metabolism and Toxicokinetic Data of Designer Drugs, Amphetamine, Methamphetamine, and Their N-Alkyl Derivatives

  2002cited by this paper
• Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for determination of amphetamine and methamphetamine enantiomers and its application to toxicology cases.

  2002cited by this paper
• Bioanalytical method validation and its implications for forensic and clinical toxicology – A review

  2002cited by this paper
• Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometry.

  2002cited by this paper
• Amphetamine‐derived Designer Drugs: Metabolism and Screening Procedures

  2002cited by this paper
• Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA ("Ecstasy")

  2002cited by this paper
• False-Positive Amphetamine Screen Following a Trazodone Overdose

  2001cited by this paper
• Fatal 4-MTA intoxication: development of a liquid chromatographic-tandem mass spectrometric assay for multiple matrices.

  2001cited by this paper
• Evaluation of Roche Abuscreen ONLINE amphetamine immunoassay for screening of new amphetamine analogues.

  2001cited by this paper
• The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

  2001influential reference
• Analysis of 4-methylthioamphetamine in clinical specimens

  2001cited by this paper
• Profiles of urine samples taken from Ecstasy users at Rave parties: analysis by immunoassays, HPLC, and GC-MS.

  2001cited by this paper
• A re-examination of the mono-methoxy positional ring isomers of amphetamine, methamphetamine and phenyl-2-propanone.

  2001cited by this paper
• Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market.

  2001cited by this paper
• 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment.

  2001cited by this paper
• [Fatal brain edema after ingestion of ecstasy and benzylpiperazine].

  2001cited by this paper
• Fatalities caused by the MDMA-related drug paramethoxyamphetamine (PMA).

  2001cited by this paper
• Amphetamines: an update on forensic issues.

  2001cited by this paper
• Three cases of fatal paramethoxyamphetamine overdose.

  2001cited by this paper
• Poisoning with the recreational drug paramethoxyamphetamine (“death”)

  2001cited by this paper
• Heptaminol interferes in the AxSYM FPIA amphetamine/methamphetamine II assay.

  2001cited by this paper
• One fatal and seven non-fatal cases of 4-methylthioamphetamine (4-MTA) intoxication: clinico-pathological findings

  2001cited by this paper
• A re-examination of the mono-methoxy positional ring isomers of amphetamine, methamphetamine and phenyl-2-propanone

  2001cited by this paper
• Bioanalytical Method Validation—A Revisit with a Decade of Progress

  2000cited by this paper
• ILLEGAL OR LEGITIMATE USE? PRECURSOR COMPOUNDS TO AMPHETAMINE AND METHAMPHETAMINE

  2000cited by this paper
• Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy').

  2000cited by this paper
• Amphetamine positive toxicology screen secondary to bupropion

  2000cited by this paper
• Screening procedures for simultaneous detection of several drug classes used for high throughput toxicological analyses and doping control. A review.

  2000cited by this paper
• Simple and simultaneous analysis of fenfluramine, amphetamine and methamphetamine in whole blood by gas chromatography-mass spectrometry after headspace-solid phase microextraction and derivatization.

  2000cited by this paper
• Fatal poisoning with a new phenylethylamine: 4-methylthioamphetamine (4-MTA).

  2000cited by this paper
• 3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

  1999cited by this paper
• Direct semiquantitative screening of drugs of abuse in serum and whole blood by means of CEDIA DAU urine immunoassays.

  1999cited by this paper
• Accuracy of five on-site immunoassay drugs-of-abuse testing devices.

  1999cited by this paper
• Para‐methylthioamphetamine, a new amphetamine designer drug of abuse

  1999cited by this paper
• Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications

  1999cited by this paper
• Fatal multi-organ failure after suicidal overdose with MDMA, `Ecstasy': case report and review of the literature

  1999cited by this paper
• Determination of "Ecstasy" components in alternative biological specimens.

  1999cited by this paper
• Systematic toxicological analysis of drugs and poisons in biosamples by hyphenated chromatographic and spectroscopic techniques.

  1999cited by this paper
• Amphetamine derivative fatalities in South Australia--is "Ecstasy" the culprit?

  1998cited by this paper
• Derivatization procedures for gas chromatographic-mass spectrometric determination of xenobiotics in biological samples, with special attention to drugs of abuse and doping agents.

  1998cited by this paper
• Recent paramethoxyamphetamine deaths.

  1998influential reference
• Validation of bioanalytical chromatographic methods.

  1998cited by this paper
• Requirements for initial assay validation and publication in J. Chromatography B.

  1998cited by this paper
• Determination of amphetamine, methamphetamine and amphetamine-derived designer drugs or medicaments in blood and urine.

  1998cited by this paper
• Determination of drugs of abuse in blood.

  1998cited by this paper
• MDMA (ecstasy) and the rave: a review.

  1997cited by this paper
• Simultaneous determination of amphetamine and its analogs in human whole blood by gas chromatography-mass spectrometry.

  1997cited by this paper
• Simultaneous gas chromatographic determination of methamphetamine, amphetamine and their p-hydroxylated metabolites in plasma and urine.

  1997cited by this paper
• Ecstasy and related substances--serum levels in impaired drivers.

  1997cited by this paper
• Amphetamine derivative related deaths.

  1997influential reference
• Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, "Eve") and its metabolites in urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay.

  1996cited by this paper
• Rational experimental design for bioanalytical methods validation. Illustration using an assay method for total captopril in plasma.

  1996cited by this paper
• Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction.

  1996cited by this paper
• Improving ion mass ratio performance at low concentrations in methamphetamine GC-MS assay through internal standard selection.

  1996cited by this paper
• Methamphetamine and driving impairment.

  1996cited by this paper
• Microwave-induced rapid preparation of fluoro-derivatives of amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine for GC-MS confirmation assays.

  1994cited by this paper
• Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites (Parts 1, 2, 3)

  1994cited by this paper
• Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans

  1994cited by this paper
• 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans.

  1994cited by this paper
• A simple wash procedure for improving chromatography of HFAA derivatized amphetamine extracts for GC/MS analysis.

  1993cited by this paper
• Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl)piperazine.

  1992cited by this paper
• Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans.

  1991cited by this paper
• Application of the Syva EMIT and Abbott TDx amphetamine immunoassays to the detection of 3,4-methylene-dioxymethamphetamine (MDMA) and 3,4-methylene-dioxyethamphetamine (MDEA) in urine.

  1990cited by this paper
• Ice: A New Dosage Form of an Old Drug

  1990influential reference
• Detection of D,L-amphetamine, D,L-methamphetamine, and illicit amphetamine analogs using diagnostic products corporation's amphetamine and methamphetamine radioimmunoassay.

  1990cited by this paper
• Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

  1988cited by this paper
• Studies on the biochemical mode of action of EGYT-475, a new antidepressant.

  1987cited by this paper
• The effect of EGYT-475 (Trelibet) and its metabolites on the potassium-stimulated 3H-noradrenaline release from cortical slices of rat brain.

  1987cited by this paper
• An investigation of the mechanism involved in the cholinergic action of meptazinol

  1987cited by this paper
• Effects of the pyrones, maltol and ethyl maltol, on iron absorption from the rat small intestine

  1987cited by this paper
• The action of trelibet, a new antidepressive agent on [3H]noradrenaline release from rabbit pulmonary artery.

  1986cited by this paper
• Determination of plasma and brain concentrations of trazodone and its metabolite, 1-m-chlorophenylpiperazine, by gas-liquid chromatography.

  1981cited by this paper
• Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts

  1973cited by this paper
• A comparison of the effects of 1-benzylpiperazine and dexamphetamine on human performance tests

  1973cited by this paper

• Metabolism of m-CPP, trazodone, nefazodone, and etoperidone: clinical and forensic aspects

  2025cites this paper
• Detection and application of 40 piperazine compounds in hair suitable for rapid separation of isomers.

  2025cites this paper
• The State of the Art in Post-Mortem Redistribution and Stability of New Psychoactive Substances in Fatal Cases: A Review of the Literature

  2024cites this paper
• Application of Carbon-based Nano Adsorbents in the Extraction of Amphetamines from Urine Samples.

  2024cites this paper
• Analysis of D- and L- Isomers of (Meth)amphetamine in Human K2EDTA Plasma

  2022cites this paper
• Analytical techniques for the detection of novel psychoactive substances and their metabolites

  2022cites this paper
• Analytical techniques for the determination of Amphetamine-type substances in different matrices: a comprehensive review

  2021cites this paper
• Automated accelerated solvent extraction coupled with ultra-high-performance liquid chromatography for the analysis of piperazine in egg samples

  2020cites this paper
• General Analytical Toxicology

  2020cites this paper
• Determination of Piperazine in Eggs Using Accelerated Solvent Extraction (ASE) and Solid Phase Extraction (SPE) with High-Performance Liquid Chromatography – Fluorescence Detection (HPLC-FLD) and Pre-Column Derivatization with Dansyl Chloride

  2020cites this paper
• Simultaneous analysis of ten drugs of abuse in blood and urine matrix by gas chromatography–mass spectrometry: Implications for air crash investigation

  2020cites this paper
• Automated accelerated solvent extraction coupled with ultra-high-performance liquid chromatography for the analysis of piperazine in egg samples

  2020cites this paper
• Determination of amphetamine-type stimulants in urine samples using microextraction by packed sorbent and gas chromatography-mass spectrometry.

  2019cites this paper
• A novel analytical method of TFMPP and mCPP in fluids of drug addicts using LLE-GC/NPD

  2019cites this paper
• The emerging field of wastewater-based epidemiology (WBE)

  2019cites this paper
• Investigating in-sewer transformation products formed from synthetic cathinones and phenethylamines using liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.

  2018cites this paper
• Determination of amphetamines-type stimulants in urine samples using microextraction by packed sorbent and gas chromatography-mass spectrometry

  2018cites this paper
• Application of gas chromatography–tandem mass spectrometry for the determination of amphetamine‐type stimulants in blood and urine

  2018cites this paper
• Qualitative und quantitative Untersuchungen von Designerdrogen und berauschenden Mitteln mittels Raman-Spektroskopie

  2018cites this paper
• Comparison of the Characteristic Mass Fragmentations of Phenethylamines and Tryptamines by Electron Ionization Gas Chromatography Mass Spectrometry, Electrospray and Matrix-Assisted Laser Desorption Ionization Mass Spectrometry

  2018cites this paper
• Quantification of piperazine in chicken and pig tissues by gas chromatography-electron ionization tandem mass spectrometry employing pre-column derivatization with acetic anhydride.

  2017cites this paper
• Quantitative determination of methamphetamine in oral fluid by liquid–liquid extraction and gas chromatography/mass spectrometry

  2017cites this paper
• Simultaneous Quantitation of Methamphetamine, Ketamine, Opiates and their Metabolites in Urine by SPE and LC-MS-MS.

  2017cites this paper
• Designer drug- Trifluoromethylphenylpiperazine derivatives (TFMPP) - A future potential peril towards modern society

  2017cites this paper
• Determination of N-methyl-1-phenol-2-propanamine trace amounts in urine samples with molecular-imprinted polymer based sorbents

  2017cites this paper
• Expert Panel Review of alternative biological matrices for use as an evidential sample for drug driving

  2017cites this paper
• Assays for Methamphetamine and Amphetamine in Blood

  2016cites this paper
• Rapid screening and determination of 11 new psychoactive substances by direct analysis in real time mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry.

  2016cites this paper
• A study to model the post-mortem stability of 4-MMC, MDMA and BZP in putrefying remains.

  2016cites this paper
• Sample pooling as an effective way of simultaneous analysis of new designer drugs together with synthetic cannabinoids in human serum provided by therapy and forensic psychiatric centres

  2016cites this paper
• Detection and quantification of 56 new psychoactive substances in whole blood and urine by LC-MS/MS.

  2015cites this paper
• Conduite automobile et amphétamines dans le sang – bases bibliographiques pour un consensus de la Société française de toxicologie analytique

  2015cites this paper
• Metabolic fate, mass spectral fragmentation, detectability, and differentiation in urine of the benzofuran designer drugs 6-APB and 6-MAPB in comparison to their 5-isomers using GC-MS and LC-(HR)-MSn techniques

  2015cites this paper
• The behavioural implications of postnatal exposure to benzylpiperazhie and methamphetamine - a longitudinal doserelated study in male and female rats.

  2015cites this paper
• Amphetamine-Derived New Psychoactive Substances : Metabolic Fate and Toxicological Detectability of Methiopropamine , three Methyl-Amphetamine Isomers , Camfetamine , 5-APB , 6-APB , 5-MAPB , and 6-MAPB in Urine and Human Liver Preparations Using

  2015cites this paper
• In Vitro Toxicity Evaluation Of Piperazine Designer Drugs

  2015cites this paper
• Studies on Human Pharmaceuticals in Jordanian Wastewater Samples

  2015cites this paper
• WITHDRAWN: GC–MS and IR studies on the six possible ring regioisomeric dimethylphenylpiperazines (DMPPs)

  2015cites this paper
• Mass Spectral and Chromatographic Studies on Some Halogenatedphenyl-2-Piperazinopropanones.

  2015cites this paper
• Comparison of hollow fiber liquid-phase microextraction and ultrasound-assisted low-density solvent dispersive liquid-liquid microextraction for the determination of drugs of abuse in biological samples by gas chromatography-mass spectrometry.

  2015cites this paper
• Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MSn techniques

  2015cites this paper
• Development and validation of an LC-MS/MS method after chiral derivatization for the simultaneous stereoselective determination of methylenedioxy-methamphetamine (MDMA) and its phase I and II metabolites in human blood plasma.

  2015cites this paper
• Analysis of synthetic drugs by differential scanning calorimetry

  2015cites this paper
• GC‐MS and IR Studies on the Six Ring Regioisomeric Dimethoxyphenylpiperazines (DOMePPs)

  2015cites this paper
• In vitro cytochrome P450 inhibition potential of methylenedioxy-derived designer drugs studied with a two-cocktail approach

  2014cites this paper
• Regioisomeric bromodimethoxy benzyl piperazines related to the designer substance 4-bromo-2,5-dimethoxybenzylpiperazine: GC-MS and FTIR analysis.

  2014cites this paper
• Issues Affecting Interpretation: Stability and Artefacts

  2014cites this paper
• Differentiation of the 1-(methylenedioxyphenyl)-2-piperazinopropanes and 1-(methoxyphenyl)-2-piperazinopropanones by GC-IRD and GC-MS.

  2014cites this paper
• Quality Assurance of forensic investigations in toxicology and traffic safety

  2014influential citation
• Studies on the metabolism and the detectability of 4-methyl-amphetamine and its isomers 2-methyl-amphetamine and 3-methyl-amphetamine in rat urine using GC-MS and LC-(high-resolution)-MSn

  2014cites this paper
• PAPER CRIMINALISTICS

  2014cites this paper
• SPIN TIP SOLID-PHASE EXTRACTION AND HILIC-MS-MS FOR QUANTITATIVE DETERMINATION OF METHAMPHETAMINE AND AMPHETAMINE IN HUMAN PLASMA

  2014cites this paper
• Development of a targeted GC/MS screening method and validation of an HPLC/DAD quantification method for piperazines-amphetamines mixtures in seized material

  2014cites this paper
• Multicomponent LC-MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine-experience from the Swedish population.

  2013cites this paper
• Screening of methylenedioxyamphetamine- and piperazine-derived designer drugs in urine by LC-MS/MS using neutral loss and precursor ion scan.

  2013cites this paper
• Forensic Drug Analysis

  2013cites this paper
• Qualitative Research of Online Drug Misuse Communities with Reference to the Novel Psychoactive Substances

  2013cites this paper
• Separation and determination of chlorophenylpiperazine isomers in confiscated pills by capillary electrophoresis.

  2013cites this paper
• Scheduled multiple reaction monitoring algorithm as a way to analyse new designer drugs combined with synthetic cannabinoids in human serum with liquid chromatography-tandem mass spectrometry.

  2013cites this paper
• Update on 1-benzylpiperazine (BZP) party pills

  2013cites this paper
• Drugs of abuse: type and methods of analysis

  2013cites this paper
• GC-MS and GC-IRD studies on the six-ring regioisomeric dimethoxybenzylpiperazines (DMBPs).

  2013cites this paper
• Identification of Designer Drug 2C-E (4-Ethyl-2, 5-Dimethoxyphenethylamine) in Urine Following a Drug Overdose

  2013cites this paper
• A Fatality Following Ingestion of the Designer Drug Meta‐Chlorophenylpiperazine (mCPP) in an Asthmatic—HPLC‐MS/MS Detection in Biofluids and Hair

  2013cites this paper
• Comprehensive forensic toxicological analysis of designer drugs

  2013influential citation
• GC-MS and GC-IRD studies on the six ring regioisomeric dimethoxybenzoylpiperazines (DMBzPs).

  2013cites this paper
• Determination of N-benzylpiperazine in human plasma using derivatization-free liquid–liquid extraction and gas chromatography mass spectrometry

  2013cites this paper
• Development and validation of a gas chromatography/mass spectrometry method for simultaneous quantification of benzylpiperazine and its metabolites: Application to a pilot toxicokinetic study in mice

  2013cites this paper
• Simultaneous determination of N-benzylpiperazine and 1-(3-trifluoromethylphenyl)piperazine in rat plasma by HPLC-fluorescence detection and its application to monitoring of these drugs.

  2012cites this paper
• Criterios cualitativos en toxicología forense

  2012cites this paper
• The effect of the postmortem interval on the redistribution of drugs: a comparison of mortuary admission and autopsy blood specimens

  2012cites this paper
• Differentiation of methoxybenzoylpiperazines (OMeBzPs) and methylenedioxybenzylpiperazines (MDBPs) By GC-IRD and GC-MS.

  2012cites this paper
• Androgens and the masculinisation programming window

  2012cites this paper
• Differentiation of methylbenzylpiperazines (MBPs) and benzoylpiperazine (BNZP) using GC-MS and GC-IRD.

  2012cites this paper
• Psychoactive Phenethylamine, Piperazine, and Pyrrolidinophenone Derivatives

  2012cites this paper
• Differentiation of methylenedioxybenzylpiperazines and ethoxybenzylpiperazines by GC-IRD and GC-MS.

  2012cites this paper
• Identification of cathinones and other active components of ‘legal highs’ by mass spectrometric methods

  2012cites this paper
• Selective Multivariate Applications In Forensic Science

  2012cites this paper
• Piperazine compounds as drugs of abuse.

  2012cites this paper
• Cat and mouse: the analytical toxicology of designer drugs.

  2011cites this paper
• The clinical toxicology of the designer “party pills” benzylpiperazine and trifluoromethylphenylpiperazine

  2011cites this paper
• Ultra-performance liquid chromatography-tandem mass spectrometry method for the analysis of amphetamines in plasma.

  2011cites this paper
• Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone)

  2011cites this paper
• Current awareness of piperazines: pharmacology and toxicology.

  2011cites this paper
• Fragmentation Pathways of Trifluoroacetyl Derivatives of Methamphetamine, Amphetamine, and Methylenedioxyphenylalkylamine Designer Drugs by Gas Chromatography/Mass Spectrometry

  2011cites this paper
• Colorimetric detection and chromatographic analyses of designer drugs in biological materials: a comprehensive review

  2011cites this paper
• Differentiation of methylenedioxybenzylpiperazines (MDBPs) and methoxymethylbenzylpiperazines (MMBPs) By GC-IRD and GC-MS.

  2011cites this paper
• Trends in bioanalytical methods for the determination and quantification of club drugs: 2000-2010.

  2011cites this paper
• Development and validation of LC-HRMS and GC-NICI-MS methods for stereoselective determination of MDMA and its phase I and II metabolites in human urine.

  2011cites this paper
• Acute administration of 3,4-methylenedioxymethamphetamine (MDMA) induces oxidative stress, lipoperoxidation and TNFα-mediated apoptosis in rat liver.

  2011cites this paper
• Determination of phenylalkylamine compounds using surface-assisted desorption/ionization from amorphous silicon

  2010cites this paper
• Differentiation of methylenedioxybenzylpiperazines (MDBP) by GC-IRD and GC-MS.

  2010cites this paper
• Bioanalysis of new designer drugs.

  2010cites this paper
• Myocardial expression of TNF-alpha, IL-1beta, IL-6, IL-8, IL-10 and MCP-1 after a single MDMA dose administered in a rat model.

  2010cites this paper
• Analysis of phenylpiperazine-like stimulants in human hair as trimethylsilyl derivatives by gas chromatography-mass spectrometry.

  2010cites this paper
• Analytical Toxicology of Emerging Drugs of Abuse

  2010cites this paper
• Separation of positional CPP isomers by chiral HPLC-DAD of seized tablets

  2010cites this paper
• Gas chromatography-ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine.

  2010cites this paper
• BENZYLOPIPERAZYNA I JEJ POCHODNE

  2010cites this paper
• Analytical toxicology

  2010cites this paper